Cytotoxicity and enzymatic activity inhibition in cell lines treated with novel iminosugar derivatives

Glycoconjugate Journal

Volumn 27, Issue 2, 2010, Pages 277-285

  Padró, Mercè ^a   Castillo, José A ^b   Gómez, Livia ^b   Joglar, Jesús ^b   Clapés, Pere ^b   De Bolos, Carme ^a  

^a HOSPITAL DEL MAR   (Spain)

^b INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

Author keywords

Cytotoxicity; Glycosidase; Iminosugar; N alkylated iminosugars

Indexed keywords

2 (HYDROXYMETHYL) 5 METHYLPYRROLIDINE 3,4 DIOL; ALPHA GLUCOSIDASE; ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; ANTINEOPLASTIC AGENT; BETA GALACTOSIDASE; DEXTRO FAGOMINE; DEXTRO FAGOMINE DERIVATIVE; GLYCOSIDASE; GLYCOSIDASE INHIBITOR; IMINOSUGAR; N 1 DODECYL 2 (HYDROXYMETHYL) 5 METHYLPYRROLIDINE 3,4 DIOL; N BUTYL DEXTRO FAGOMINE; N DODECYL DEXTRO FAGOMINE; N NONYL DEXTRO FAGOMINE; N OCTYL DEXTRO FAGOMINE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL LYSATE; CELL STRAIN MCF 7; COLON CANCER; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; STOMACH CANCER;

CELL DEATH; CELL EXTRACTS; CELL LINE, TUMOR; CELL SURVIVAL; GLUCOSIDES; GLYCOSIDE HYDROLASES; GLYCOSIDES; HUMANS; IMINO PYRANOSES; PHENOTYPE; PYRROLIDINES;

EID: 77949268957     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-009-9276-3     Document Type: Article

References (20)

1. K Ohtsubo JD Marth 2006 Glycosylation in cellular mechanisms of health and disease Cell 126 855 867 10.1016/j.cell.2006.08.019 1:CAS:528: DC%2BD28XpvVKitbo%3D 16959566 (Pubitemid 44310784)
2. B Winchester GW Fleet 1992 Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists Glycobiology 2 199 210 10.1093/glycob/2.3.199 1:CAS:528:DyaK38XlsVOltrw%3D 1498417
3. TD Butters RA Dwek FM Platt 2005 Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses Glycobiology 15 43R 52R 10.1093/glycob/cwi076 1:CAS:528:DC%2BD2MXhtVelsb7N 15901676 (Pubitemid 41511483)
4. T Cox R Lachmann C Hollak J Aerts S van Weely M Hrebicek F Platt T Butters R Dwek C Moyses I Gow D Elstein A Zimran 2000 Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis Lancet 355 1481 1485 10.1016/S0140-6736(00)02161-9 1:CAS:528:DC%2BD3cXjt1alt7g%3D 10801168
5. L Yu K Ikeda A Kato I Adachi G Godin P Compain O Martin N Asano 2006 Alpha-1-C-octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease Bioorg. Med. Chem. 14 7736 7744 10.1016/j.bmc.2006.08.003 1:CAS:528:DC%2BD28XhtFSrtLvL 16919960 (Pubitemid 44584721)
6. I Robina AJ Moreno-Vargas AT Carmona P Vogel 2004 Glycosidase inhibitors as potential HIV entry inhibitors? Curr. Drug Metab 5 329 361 10.2174/1389200043335513 1:CAS:528:DC%2BD2cXlsleksrk%3D 15320705 (Pubitemid 38997447)
7. A Mitrakou N Tountas AE Raptis RJ Bauer H Schulz SA Raptis 1998 Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus Diabet. Med. 15 657 660 10.1002/(SICI)1096-9136(199808)15:8<657::AID-DIA652>3.0.CO;2-7 1:STN:280:DyaK1czmslyntw%3D%3D 9702468 (Pubitemid 28355849)
8. IV Alymova G Taylor A Portner 2005 Neuraminidase inhibitors as antiviral agents Curr. Drug Targets. Infect. Disord. 5 401 409 10.2174/156800505774912884 1:CAS:528:DC%2BD28XhsleltQ%3D%3D 16535861 (Pubitemid 43008513)
9. TM Wrodnigg AJ Steiner BJ Ueberbacher 2008 Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy Anticancer Agents Med. Chem. 8 77 85 10.2174/187152008783330851 1:CAS:528:DC%2BD1cXktVeisg%3D%3D 18220507
10. Y Nishimura 2003 gem-Diamine 1-N-iminosugars and related iminosugars, candidate of therapeutic agents for tumor metastasis Curr. Top. Med. Chem. 3 575 591 10.2174/1568026033452492 1:CAS:528:DC%2BD3sXntVCqug%3D%3D 12570867
11. H Fiaux F Popowycz S Favre C Schütz P Vogel S Gerber-Lemaire L Juillerat-Jeanneret 2005 Functionalized pyrrolidines inhibit activity and growth of human glioblastoma and melanoma cells J. Med. Chem. 48 4237 4246 10.1021/jm0409019 1:CAS:528:DC%2BD2MXkslSnsrc%3D 15974577 (Pubitemid 40884927)
12. S Favre H Fiaux C Schütz P Vogel L Juillerat-Jeanneret S Gerber-Lemaire 2006 Synthesis of new pyrrolidine derivatives as inhibitors of alpha-mannosidase and of glioblastoma cells growth Heterocycles 69 179 192 10.3987/COM-06-S(O)8 1:CAS:528:DC%2BD2sXhs1WksQ%3D%3D
13. A Kato N Asano H Kizu K Matsui 1997 Fagomine isomers and glycosides from Xanthocercis zambesiaca J. Nat. Prod. 60 312 314 10.1021/np960646y 1:CAS:528:DyaK2sXhvFGnsbw%3D 9157194 (Pubitemid 27146478)
14. JA Castillo J Calveras J Casas M Mitjans MP Vinardell T Parella T Inoue GA Sprenger J Joglar P Clapes 2006 Fructose-6-phosphate aldolase in organic synthesis: preparation of D-fagomine, N-alkylated derivatives, and preliminary biological assays Org. Lett. 8 6067 6070 10.1021/ol0625482 1:CAS:528: DC%2BD28Xht1Clu7rN 17165931
15. L Espelt J Bujons T Parella J Calveras J Joglar A Delgado P Clapes 2005 Aldol additions of dihydroxyacetone phosphate to N-Cbz-amino aldehydes catalyzed by L-fuculose-1-phosphate aldolase in emulsion systems: inversion of stereoselectivity as a function of the acceptor aldehyde Chemistry. 11 1392 1401 10.1002/chem.200400648 1:CAS:528:DC%2BD2MXitVOmt78%3D 15669071 (Pubitemid 40341873)
16. Compain, P., Martin, O.R. (eds.): Iminosugars: from synthesis to therapeutic applications. Wiley-VCH, Weinheim (2007)
17. N Zitzmann AS Mehta S Carrouee TD Butters FM Platt J McCauley BS Blumberg RA Dwek TM Block 1999 Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents Proc. Natl. Acad. Sci. U. S. A. 96 11878 11882 10.1073/pnas.96.21.11878 1:CAS:528:DyaK1MXmvVGjsrk%3D 10518544 (Pubitemid 29502826)
18. HR Mellor J Nolan L Pickering MR Wormald FM Platt RA Dwek GW Fleet TD Butters 2002 Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins Biochem. J. 366 225 233 1:CAS:528:DC%2BD3sXptFOht7c%3D 11982484
19. HR Mellor DC Neville DJ Harvey FM Platt RA Dwek TD Butters 2004 Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis Biochem. J. 381 861 866 10.1042/BJ20031822 1:CAS:528:DC%2BD2cXlvFKjsrc%3D 15128268 (Pubitemid 39120497)
20. PH Liang WC Cheng YL Lee HP Yu YT Wu YL Lin CH Wong 2006 Novel five-membered iminocyclitol derivatives as selective and potent glycosidase inhibitors: new structures for antivirals and osteoarthritis Chembiochem. 7 165 173 10.1002/cbic.200500321 1:CAS:528:DC%2BD28Xms1Olsw%3D%3D 16397876 (Pubitemid 43076300)